Effect of inhibition of cytochrome P450 Enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone in volunteers.

Trial Profile

Effect of inhibition of cytochrome P450 Enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone in volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 May 2011

At a glance

  • Drugs Oxycodone (Primary) ; Itraconazole; Paroxetine
  • Indications Depression; Pain
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 03 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top